Skip to main content

The discovery of RingoA-Cdk2 opens the door to the development of a male contraceptive

Images

Participants

Contact

Image
Section Head of Communication & Outreach
Tel.+34 93 40 37255

The medical website farmacosalud.com devotes an article to a new research by Angel R. Nebreda, ICREA researcher and group leader of the Signalling and Cell Cycle Laboratory, on the RingoA protein and its role in meiosis—a study recently published in Nature Communications. The article explains that RingoA plays a key role in the production of sperm and eggs and that it could become a target for a male contraceptive.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).